Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Review: Room Air May Better Help Newborns Breathe Than Oxygen

October 30, 2026 Dr. Michael Lee – Health Editor Health

When full-term or near-term babies need help to start breathing at birth, using normal air instead of extra oxygen may reduce the risk of death before leaving the hospital, according to a review updated in January 2026. However, researchers cannot be certain about this benefit because the underlying studies are not of high enough quality to establish definitive clinical certainty.

Key Clinical Takeaways:

  • Normal air (21 percent oxygen) may lower pre-discharge mortality compared to 100 percent oxygen for newborns requiring breathing assistance.
  • Using room air likely makes little or no difference in the incidence of moderate or severe hypoxic-ischaemic encephalopathy (HIE).
  • Current evidence remains limited by small sample sizes, flawed study designs, and a complete lack of rigorous long-term neurodevelopmental follow-up past one year of age.

Why do approximately one in ten term babies require breathing support at delivery?

Most newborns transition smoothly from placental oxygenation to independent pulmonary respiration immediately after birth. Yet, approximately one in ten infants born at or near term require immediate medical intervention to initiate breathing. If an infant fails to establish effective respiration independently, they risk developing asphyxia, a dangerous condition characterized by systemic oxygen deprivation that can lead to death or long-term brain injury.

Healthcare providers combat this emergency by applying positive pressure ventilation via a mask. During this critical resuscitation window, clinicians can administer standard room air containing 21 percent oxygen, or they can deliver supplemental oxygen streams scaled up to 100 percent concentration. Evaluating whether room air or concentrated oxygen yields superior survival rates and neurological preservation guides modern neonatal resuscitation protocols.

What did the 2026 review discover across twelve clinical trials?

Investigators analyzed 12 trials encompassing a total of 2,054 infants born at term or up to five weeks early. These trials, conducted across both high-income and low-to-middle-income countries, directly contrasted the administration of 21 percent room air against 100 percent oxygen during initial neonatal resuscitation. The comparative synthesis indicated that room air ventilation may decrease infant mortality prior to hospital discharge.

Despite the survival signal, the analysis revealed that room air likely exerts minimal to no impact on the reduction of moderate or severe hypoxic-ischaemic encephalopathy. HIE is a form of brain injury stemming from restricted cerebral blood flow and oxygenation around the time of birth, typically diagnosed within the first hours of life. None of the evaluated studies tracked pediatric development using widely accepted, rigorous definitions past the one-year mark, leaving long-term disability outcomes entirely unmeasured.

What methodological limitations weaken the current neonatal oxygen evidence?

Confidence in these findings remains low due to significant methodological shortcomings across the evaluated literature. Many of the 12 studies suffered from concerns about how babies were put into treatment groups and how the results were reported. The small overall sample sizes restricted the statistical power necessary to detect subtle adverse events or definitive subgroup differences.

A critical gap in the existing research is the absence of titration. While trials compared strict room air to pure oxygen, none investigated intermediate oxygen fractions or dynamically adjusted oxygen delivery based on the neonate’s actual physiological needs. Because modern hospital environments rely heavily on targeted, blended oxygen delivery rather than fixed extremes, translating these historical trial results directly into contemporary clinical practice presents substantial challenges.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • Father Argues Youth Does Not Protect Against Serious Illness
  • Monica Thomas shares lichen sclerosus diagnosis delay

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: office@world-today-news.com

Privacy Policy Terms of Service